P2RY2 and Hypertension: The previous section highlighted the detrimental activation of the ATP-P2Y2 signalling axis on VSMCs and ECs in hypertension, cardiomyocytes in myocardial atrophy, and cardiac fibroblast in myocardial fibrosis.